BioSpace News Archive

Business

Navidea Biopharmaceuticals Announces Research Agreement with the University of Pennsylvania Evaluating Tc99m Tilmanocept as a Prognostic Marker for Glioblastoma

Navidea Biopharmaceuticals, Inc. today announced the signing of a Sponsored Research Agreement with the University of Pennsylvania (“Penn”) for a project to evaluate the use of Tc99m tilmanocept imaging in glioblastoma.

February 7, 2022

·

6 min read

Biotech Bay

Avellino Launches Combination Test That Detects COVID-19, Respiratory Syncytial Virus (RSV), Influenza A and B

Avellino Lab USA, Inc. has launched AvellinoCoV2 - Respiratory Test, a multi-panel RT-PCR-based virus assay that accurately detects four viral infections in one patient sample - COVID-19, respiratory syncytial virus (RSV), influenza A and influenza B.

February 7, 2022

·

4 min read

Drug Development

NLS Pharmaceutics to Present Interim Top-Line Data for Quilience(R) (Mazindol ER) in Patients with Narcolepsy at the World Sleep Congress in March 2022

NLS Pharmaceutics Ltd. announces that it will present interim top-line data from its Phase 2a clinical trial evaluating its lead product candidate, Quilience.

February 7, 2022

·

7 min read

BioMidwest

Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2022 MedTech R&D Spotlight Call Series

Inspire Medical Systems, Inc. announced that its management team will be participating in the Wells Fargo 2022 MedTech R&D Spotlight Call Series on February 18, 2022.

February 7, 2022

·

1 min read

Biotech Beach

Daré Bioscience to Participate in Upcoming Conferences in February 2022

Daré Bioscience, Inc., a leader in women’s health innovation, announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will participate in the following upcoming conferences.

February 7, 2022

·

3 min read

Business

Axcella Therapeutics Announces Appointment of New Chief Financial Officer

Axcella Therapeutics today announced the appointment of Robert Crane as the company’s new Chief Financial Officer.

February 7, 2022

·

5 min read

Business

AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 14, 2022

Applied Genetic Technologies Corporation today announced that it will report financial results for the quarter ended December 31, 2021 before the market opens on Monday, February 14, 2022.

February 7, 2022

·

2 min read

Biotech Beach

aTyr Pharma to Present at BIO CEO & Investor Conference

aTyr Pharma, Inc. announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will present a corporate overview at the BIO CEO & Investor Conference, which is being held February 14 – 17, 2022, at the Marriott Marquis in New York, NY.

February 7, 2022

·

1 min read

Alimera Sciences Announces Launch of ILUVIEN® for Uveitis in SpainILUVIEN received pricing approval for non-infectious posterior uveitis indication in December

Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), announces that Alimera Sciences Europe Limited, its Ireland-based European subsidiary, will launch ILUVIEN® for non-infectious posterior uveitis in Spain, through its distribution partner, Brill Pharma (Brill).

February 7, 2022

·

5 min read

Business

VistaGen Therapeutics to Report Fiscal Year 2022 Third Quarter Financial Results on February 10, 2022

VistaGen Therapeutics, Inc will host a conference call and webcast on Thursday, February 10, 2022 at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to report its financial results for its fiscal year 2022.

February 7, 2022

·

1 min read